# Specimens | # Cases | ||||
Malignant – 1° | Carcinoma – Serous | Sx | Unmatched | 129 | 65 |
Malignant – 1° | Carcinoma – Serous | Sx | Matched | 0 | 0 |
Malignant 1° <10% T | Carcinoma – Serous | Sx | Unmatched | 4 | 3 |
Malignant – 1° & Met | Carcinoma – Serous | Sx | 1° & Met | 41 | 14 |
Malignant – 1° & Met <10% T | Carcinoma – Serous | Sx | 1° & Met | 2 | 1 |
Malignant – Mets | Carcinoma – Serous | Sx | Unmatched | 120 | 57 |
Malignant – Mets <10% T | Carcinoma – Serous | Sx | Unmatched | 11 | 5 |
Carcinoma – Serous – 1° | Sx | 1 | |||
Primary w/fluid match | Matching Plasma | 14 | 1 | ||
Matching Buffy Coat | 2 | ||||
Malignant – 1° | Carcinoma – Mucinous | Sx | Unmatched | 15 | 11 |
Malignant – Mets | Carcinoma – Mucinous | Sx | Unmatched | 8 | 4 |
Malignant – 1° | Carcinoma – Clear Cell | Sx | Unmatched | 8 | 2 |
Malignant 1° <10% T | Carcinoma – Clear Cell | Sx | Unmatched | 1 | 1 |
Malignant – Mets | Carcinoma – Clear Cell | Sx | Unmatched | 5 | 2 |
Malignant – 1° | Carcinoma – Endometrioid | Sx | Unmatched | 45 | 17 |
Malignant – 1° | Carcinoma – Endometrioid | Sx | Matched | 1 | 1 |
Malignant 1° <10% T | Carcinoma – Endometrioid | Sx | Unmatched | 1 | 1 |
Malignant – 1° & Met | Carcinoma – Endometrioid | Sx | 1° & Met | 8 | 2 |
Malignant – Mets | Carcinoma – Endometrioid | Sx | Unmatched | 8 | 5 |
Malignant – 1° | Carcinoma – Mixed | Sx | Unmatched | 18 | 12 |
Malignant – Mets | Carcinoma – Mixed | Sx | Unmatched | 8 | 3 |
Malignant – 1° | Carcinoma – NOS | Sx | Unmatched | 3 | 1 |
Malignant – Mets | Carcinoma – NOS | Sx | Unmatched | 11 | 6 |
Malignant – 1° | Mixed Mullerian Tumor | Sx | Unmatched | 16 | 10 |
Malignant 1° <10% T | Mixed Mullerian Tumor | Sx | Unmatched | 1 | 1 |
Malignant – Mets | Mixed Mullerian Tumor | Sx | Unmatched | 3 | 3 |
Malignant – 1° & Met | Mixed Mullerian Tumor | Sx | Unmatched | 4 | 2 |
Malignant – Mets | Cystadenocarcinoma – Serous | Sx | Unmatched | 5 | 4 |
Malignant | Granulosa Cell Tumor – Adult Type | Sx | Unmatched | 12 | 8 |
Malignant w/match NL | Granulosa Cell Tumor – Adult Type | Sx | Matched | 2 | 1 |
Malignant | Granulosa Cell Tumor – Juvenile Type | Sx | Unmatched | 7 | 2 |
Indeterminate | Granulosa Cell Tumor – NOS | Sx | Unmatched | 5 | 3 |
Malignant – Mets | Granulosa Cell Tumor – NOS | Sx | Unmatched | 1 | 1 |
Malignant | Extra-ovarian Carcinoma – Serous | Sx | Unmatched | 3 | 2 |
Malignant | Extra Ovarian Mixed | Sx | Unmatched | 2 | 1 |
Malignant 1° <10% T | Transitional Cell Ca of Ovary | Sx | Unmatched | 2 | 2 |
Malignant – 1° | Squamous Cell Ca of Ovary | Sx | Unmatched | 1 | 1 |
Malignant | Steroid Cell Tumor – NOS | Sx | Unmatched | 1 | 1 |
Malignant – 1° & Met | Carcinoma – Small Cell type | Sx | Unmatched | 2 | 1 |
Malignant | Adenocarcinoma, signet ring cell | Sx | Unmatched | 1 | 1 |
Malignant | Endometrial stromal sarcoma | Sx | Unmatched | 3 | 1 |
Malignant | Epitheliod cell neoplasm (PEComa) | Sx | Unmatched | 1 | 1 |
Malignant | Neuroendocrine Tumor | Sx | Unmatched | 2 | 1 |
Primary | Germ Cell Tumor | Sx | Unmatched | 23 | 12 |
Germ Cell Tumor | Sx | 2 | |||
Primary w/fluid match | Matching Plasma | 9 | 1 | ||
Matching Buffy Coat | 2 | ||||
Borderline | Mucinous | Sx | Unmatched | 31 | 18 |
Borderline | Mucinous | Sx | Matched | 2 | 1 |
Borderline | Serous | Sx | Unmatched | 24 | 13 |
Borderline | Serous | Sx | Matched | ||
Indeterminant | Sertoli-Leydig Cell Tumor | Sx | Unmatched | 12 | 1 |
Benign Tumor | Adenofibroma – Serous | Sx | Unmatched | 2 | 2 |
Adenofibroma – Serous | Sx | Matched Fluid | 3 | ||
Benign Tumor w/matching fluid | Matching plasma | Sx | 2 | 1 | |
Matching serum | Sx | 2 | |||
Benign Tumor | Fibroma | Sx | Unmatched | 19 | 10 |
Benign Tumor | Fibroma | Sx | Matched | 1 | 1 |
Benign Tumor | Cystadenoma – Serous | Sx | Unmatched | 21 | 13 |
Benign Tumor | Cystadenoma – Serous | Sx | Matched | 2 | 1 |
Benign Tumor | Cystadenoma – Mucinous | Sx | Unmatched | 15 | 10 |
Benign Tumor | Cystadenoma – Mixed | Sx | Unmatched | 3 | 2 |
Benign Tumor | Fibrothecoma | Sx | Unmatched | 45 | 17 |
Benign Tumor | Fibrothecoma | Sx | Matched | 2 | 1 |
Benign Tumor | Cystadenofibroma | Sx | Unmatched | 16 | 8 |
Benign Tumor | Gynandroblastoma | Sx | Unmatched | 2 | 1 |
Benign Tumor | Brenner Tumor | Sx | Unmatched | 13 | 6 |
Benign Tumor | Lipoleiomyoma | Sx | Unmatched | 1 | 1 |
Benign | Cyst | Sx | Unmatched | 12 | 9 |
Benign | Ovary w/cortical stromal fibrosis | Sx | Unmatched | 5 | 1 |
Benign | Ovary w/hemorrhage | Sx | Unmatched | 13 | 4 |
Benign | Ovary smooth muscle | Sx | Unmatched | 4 | 1 |
Benign | Fibroadipose tissue | Sx | Unmatched | 10 | 5 |
Benign | Strumovarii | Sx | Unmatched | 1 | 1 |
Benign | Endometriosis | Sx | Unmatched | 2 | 2 |
Benign | Fibrous Tissue | Sx | Unmatched | 8 | 5 |
Benign | Fibrovascular Tissue | Sx | Unmatched | 4 | 4 |
Benign | w/physiological changes | Sx | Unmatched | 6 | 4 |
Benign | NOS | Sx | Unmatched | 1 | 1 |
Normal/Uninvolved | From GYN cancer patient | Sx | 46 | 38 | |
Normal | From non-cancer patient | Sx | 40 | 31 | |
Normal/Uninvolved | From pt w/mets cancer to ovary | Sx | 3 | 3 | |
Normal/Uninvolved | From pt w/CIN | Sx | 1 | 1 | |
TOTAL | 948 | 491 |